MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Randomized, Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of ABBV-0805, an Anti-Alpha-Synuclein Monoclonal Antibody in Healthy Subjects

    H. Kalluri, C. Zadikoff, L. Rueter, O. Graff, H. Xiong (North Chicago, USA)

    Objective: To evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of ABBV-0805 following administration of single ascending doses of ABBV-0805, administered as intravenous (IV) infusions…
  • MDS Virtual Congress 2021

    Decreased expression of trace amines receptors on lymphocytes in Parkinson’s disease

    Z. Muruzheva, I. Ivleva, V. Maystrenko, O. Tumashova, M. Karpenko (Saint-Petersburg, Russian Federation)

    Objective: To determine the expression of TAAR1 and TAAR2 mRNA in leukocytes of patients with Parkinson's disease, depending on the stage of the disease and…
  • MDS Virtual Congress 2021

    Potential drug-drug interactions in hospitalized patients with Parkinson’s disease from tertiary center in Serbia

    D. Aleksic, S. Stefanovic, M. Milosavljevic, J. Milosavljevic, S. Jankovic (Kragujevac, Serbia)

    Objective: The aim of this study was to identify predictors of potential drug-drug interactions in patients suffering from Parkinson’s disease.The aim of this study was…
  • MDS Virtual Congress 2021

    Assessment of Fluctuating Parkinson’s Disease with Sensor-Based Home Monitoring-Feasibility Results

    T. Fay-Karmon, N. Galor, B. Heimler, R. Bartsch, A. Zilka, V. Livneh, M. Plotnik, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: To implement home-based monitoring (HBM) using wearable devices, a smartphone dedicated app and patient reported outcomes in order to provide a more comprehensive picture…
  • MDS Virtual Congress 2021

    Findings from a Community-based LOUD Crowd® Program for People with Parkinson Disease

    S. Parveen, A. Mandaville (Stillwater, USA)

    Objective: SPEAK OUT!® and LOUD Crowd® programs target the communicative functioning of people with Parkinson disease (PD). The current study includes findings from a year-long…
  • MDS Virtual Congress 2021

    Combined Plantar Stimulations Using a Novel Parkinson Shoe benefit Parkinson’s Disease Patients with Unresponsive Freezing of Gait

    W. Phuenpathom, P. Panyakaew, S. Fungtammasan, P. Vateekul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the effect of combined vibratory and pressure stimulations in PD patients with unresponsive FOG and develop the innovative PD shoe. Background: Freezing…
  • MDS Virtual Congress 2021

    Levodopa responsive gait dynamics in ON- and OFF-state freezing of gait in Parkinson’s disease

    T. Virmani, L. Pillai, A. Glover, R. Landes (Little Rock, USA)

    Objective: To determine which spatiotemporal gait parameters respond to levodopa in Parkinson’s patients with levodopa ON- and OFF-state gait freezing. Background: Levodopa-ON-state gait freezing is…
  • MDS Virtual Congress 2021

    EPIDEMIOLOGICAL OVERVIEW OF PARKINSON’S DISEASE IN BRAZIL

    S. Moura, R. Oliveira, L. Cruz, N. Cruz, A. Moura, N. Oliveira (Salvador, Brazil)

    Objective: To describe the epidemiological profile in patients hospitalized with Parkinson's Disease in Brazil during the years 2015 to 2020. Background: Parkinson's disease (PD) is…
  • MDS Virtual Congress 2021

    Machine Learning (ML) Prediction of Parkinson’s Disease (PD) Risk and Nigral Neuron Density

    I. Karabayir, L. Butler, S. Goldman, R. Kamaleswaran, F. Gunturkun, R. Davis, GW. Ross, H. Petrovitch, K. Masaki, C. Tanner, G. Tsivgoulis, A. Alexandrov, O. Akbilgic (Maywood, USA)

    Objective: To investigate associations between nigral neuron density and ML-based PD risk prediction. Background: Early identification of persons at high risk for developing PD is…
  • MDS Virtual Congress 2021

    Plasma phosphorylated α-synuclein relates to cognitive impairment in patients with Parkinson’s disease

    N-N. Che (Nangjing, China)

    Objective: To investigate whether plasma phosphorylated α-synuclein (p-syn) were associated with cognitive function in Parkinson’s disease (PD). Background: Parkinson’s disease (PD) is the second most…
  • « Previous Page
  • 1
  • …
  • 333
  • 334
  • 335
  • 336
  • 337
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley